Multi-center study of construction of normal database for 123I-ioflupan SPECT
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 26 Sep 2017
At a glance
- Drugs Ioflupane 123I (Primary)
- Indications Dementia; Essential tremor; Multiple system atrophy; Parkinsonian disorders; Progressive supranuclear palsy
- Focus Diagnostic use
- 20 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 16 Sep 2015 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov record.
- 17 Mar 2015 New trial record